UPXI - Upexi Inc Stock Price, Fair Value and News

0.50USD0.00 (0.00%)Market Closed

Market Summary

USD0.500.00

Market Closed

0.00%

UPXI Alerts

1 major insider buys recently.

UPXI Stock Price

View Fullscreen

UPXI RSI Chart

UPXI Valuation

Market Cap

10.4M

Price/Earnings (Trailing)

-0.46

Price/Sales (Trailing)

0.11

EV/EBITDA

-0.47

Price/Free Cashflow

-1.5

UPXI Price/Sales (Trailing)

UPXI Profitability

Operating Margin

37.58%

EBT Margin

-21.50%

Return on Equity

-89.83%

Return on Assets

-36.8%

Free Cashflow Yield

-66.71%

UPXI Fundamentals

UPXI Revenue

Revenue (TTM)

91.5M

Rev. Growth (Yr)

-18.37%

Rev. Growth (Qtr)

-20.18%

UPXI Earnings

Earnings (TTM)

-22.9M

Earnings Growth (Yr)

-194.34%

Earnings Growth (Qtr)

-79.74%

Breaking Down UPXI Revenue

Last 7 days

4.2%

Last 30 days

-19.3%

Last 90 days

-62.4%

How does UPXI drawdown profile look like?

UPXI Financial Health

Current Ratio

0.93

UPXI Investor Care

Shares Dilution (1Y)

16.31%

Diluted EPS (TTM)

-0.93

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	72.0M	80.3M	96.5M	91.5M
2022	23.9M	23.1M	30.4M	52.2M
2021	19.9M	24.1M	25.0M	25.8M
2020	0	7.4M	11.6M	15.8M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Upexi Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 12, 2024	marshall allan	bought	36,565	0.57	64,150	chief executive officer
Mar 11, 2024	marshall allan	bought	8,173	0.6	13,623	chief executive officer
Mar 05, 2024	marshall allan	bought	72,109	0.7	103,013	chief executive officer
Dec 15, 2023	marshall allan	bought	4,126	0.91	4,535	chief executive officer
Dec 14, 2023	marshall allan	bought	8,213	0.98	8,381	chief executive officer
Dec 07, 2023	marshall allan	bought	84,951	0.9439	90,001	chief executive officer
Dec 05, 2023	marshall allan	bought	16,293	0.8444	19,296	chief executive officer
Dec 04, 2023	marshall allan	bought	24,358	0.7127	34,178	chief executive officer
Jun 28, 2023	marshall allan	bought	54,168	2.257	24,000	chief executive officer
Jun 27, 2023	marshall allan	bought	57,288	2.387	24,000	chief executive officer

Which funds bought or sold UPXI recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 25, 2024	SIMPLEX TRADING, LLC	reduced	-32.42	-1,000	-	-%
Apr 24, 2024	PSI Advisors, LLC	new	-	6,972	6,972	-%
Apr 17, 2024	Evergreen Private Wealth LLC	sold off	-100	-27.00	-	-%
Mar 11, 2024	VANGUARD GROUP INC	added	5.49	-135,918	328,440	-%
Feb 14, 2024	STATE STREET CORP	unchanged	-	-9,613	19,563	-%
Feb 14, 2024	BANK OF AMERICA CORP /DE/	new	-	20.00	20.00	-%
Feb 14, 2024	Walleye Capital LLC	sold off	-100	-217,980	-	-%
Feb 14, 2024	Squarepoint Ops LLC	added	23.5	-8,385	40,384	-%
Feb 14, 2024	CORSAIR CAPITAL MANAGEMENT, L.P.	sold off	-100	-54,296	-	-%
Feb 14, 2024	Royal Bank of Canada	added	1,454	-	-	-%

Are Funds Buying or Selling UPXI?

Are funds buying UPXI calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own UPXI

No. of Funds

UPXI Alerts

1 major insider buys recently.

Recent SEC filings of Upexi Inc

View All Filings

Date Filed	Form Type	Document
Apr 02, 2024	8-K	Current Report
Mar 20, 2024	8-K	Current Report
Mar 18, 2024	4	Insider Trading
Mar 08, 2024	8-K	Current Report
Mar 06, 2024	4	Insider Trading
Feb 16, 2024	8-K	Current Report
Feb 14, 2024	10-Q	Quarterly Report
Feb 12, 2024	8-K	Current Report
Feb 02, 2024	8-K	Current Report

Peers (Alternatives to Upexi Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
GOOG	2.1T	318.1B	14.26%	60.19%	26.08	6.76	11.78%	40.66%
META	1.1T	142.7B	-10.23%	85.83%	24.66	7.91	21.62%	113.38%
DASH	51.9B	8.6B	-4.87%	126.14%	-93.03	6.01	31.17%	59.12%
SNAP	24.6B	4.8B	26.99%	38.48%	-18.94	5.11	6.28%	7.14%
MID-CAP
MTCH	8.5B	3.4B	-11.15%	-8.89%	13.12	2.54	5.51%	81.01%
YELP	2.8B	1.3B	4.40%	38.14%	28.1	2.08	12.03%	172.85%
SMALL-CAP
GETY	1.6B	916.6M	-7.75%	-	81.48	1.74	-1.05%	125.21%
EVER	657.9M	287.9M	4.21%	181.56%	-12.83	2.29	-28.75%	-110.05%
GRPN	455.2M	514.9M	-8.89%	208.99%	-8.21	0.88	-14.05%	76.68%
SCOR	65.9M	371.3M	-9.77%	-29.34%	-0.83	0.18	-1.35%	-19.23%
IZEA	48.4M	36.2M	24.36%	21.25%	-6.58	1.34	-11.88%	-64.43%
DGLY	5.5M	28.2M	-23.35%	-37.66%	-0.23	0.2	-23.67%	-236.48%

Upexi Inc News

Latest updates

Upexi Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2
Revenue	-20.2%	21,827,827	27,347,642	18,155,042	24,219,445	26,741,562	11,218,799	9,784,779	4,426,898	4,983,557	3,870,110	10,645,175	6,347,514	4,164,894	2,937,442	-
Cost Of Revenue	-27.3%	13,556,574	18,639,793	10,330,332	14,614,754	16,655,117	5,401,316	5,114,623	1,098,137	711,246	1,271,729	5,391,854	2,950,802	2,234,259	1,619,208	-
Gross Profit	-5.0%	8,271,253	8,707,849	7,824,710	9,604,691	10,086,445	5,817,483	4,670,156	3,328,761	4,272,311	2,598,381	5,253,321	3,396,712	1,930,635	1,318,234	-
Operating Expenses	2.1%	10,058,374	9,850,003	12,412,936	12,003,387	11,786,901	134,625	6,206,470	4,866,492	6,808,272	3,477,507	3,838,507	2,381,408	2,173,930	2,078,320	-
S&GA Expenses	-5.5%	2,691,368	2,848,667	1,520,086	3,476,918	3,297,144	1,727,469	1,295,787	1,085,823	1,735,194	1,000,064	907,356	656,151	459,446	365,258	-
EBITDA Margin	2.2%	-0.20	-0.21	-0.23	-0.03	-0.02	-0.19	-0.15	-0.02	0.08	0.19	0.13	-0.23	-0.29	-0.40	-0.63
Interest Expenses	-223.2%	-1,077,084	874,185	-2,816,007	-154,999	-1,789,299	433,478	-144,916	-19,705	-48,541	15,538	663,730	-48,541	-42,049	-42,691	-
Income Taxes	47.1%	694,807	472,367	3,546,173	-496,880	-755,253	708,201	1,870,084	-1,351,686	-493,936	258,903	1,282,815	-	-	-	-
Earnings Before Taxes	-111.2%	-2,864,205	-1,356,388	-12,910,416	-2,553,695	-3,493,295	-2,745,520	-2,413,152	-1,551,936	-2,584,501	894,664	1,435,923	966,763	102,520	-809,073	-
EBT Margin	-2.1%	-0.22	-0.21	-0.23	-0.06	-0.06	-0.31	-0.25	-0.08	0.03	0.14	0.07	-0.27	-0.34	-0.46	-0.73
Net Income	-79.7%	-2,437,919	-1,356,388	-17,311,061	-1,768,688	2,584,098	-2,745,520	-2,046,030	-52,667	64,833	511,711	2,718,738	966,763	102,520	-809,073	-
Net Income Margin	-35.0%	-0.25	-0.19	-0.24	-0.05	-0.04	-0.16	-0.07	0.14	0.16	0.17	0.12	0.00	0.00	0.00	0.00
Free Cashflow	93.0%	-183,930	-2,640,560	-3,977,243	-166,334	6,077,646	-2,668,957	-2,150,049	409,876	-4,542,919	650,488	1,525,717	695,118	-61,019	-642,639	-

Balance Sheet

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Balance Sheet												(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2020Q2
Assets	-4.7%	62,161	65,246	63,853	73,815	76,637	49,101	48,491	33,153	35,205	29,212	27,255	6,402
Current Assets	-9.4%	22,583	24,918	25,456	20,095	22,125	18,803	17,062	10,261	12,098	17,789	18,293	2,650
Cash Equivalents	342.2%	1,844	417	4,492	1,181	4,508	3,299	7,150	4,503	6,596	13,035	14,534	888
Inventory	6.4%	14,664	13,786	11,557	10,141	6,780	6,090	11,557	3,561	3,681	3,092	2,095	1,448
Net PPE	-1.9%	7,600	7,745	7,526	7,618	7,231	7,368	7,339	7,682	7,440	2,893	2,832	1,687
Goodwill	0.8%	11,809	11,719	10,251	15,057	15,342	6,223	4,645	8,534	8,534	3,686	2,414	2,414
Current Liabilities	21.1%	24,256	20,037	19,606	17,682	15,095	11,730	10,128	4,373	5,263	4,250	5,819	3,519
Shareholder's Equity	-7.6%	25,463	27,570	27,837	37,034	36,746	27,039	28,787	28,416	29,521	24,778	21,218	2,179
Retained Earnings	-9.9%	-26,995	-24,557	-23,201	-7,842	-6,198	-8,868	-6,270	-3,646	-3,593	-3,658	-4,170	-7,098
Additional Paid-In Capital	0.6%	52,437	52,107	51,522	44,858	43,105	35,983	34,986	32,046	33,097	28,421	25,372	7,314
Shares Outstanding	0.4%	20,398	20,307	16,713	18,095	17,961	16,713	16,713	16,081	9,756	15,452	15,262	15,262
Minority Interest	-	-	-	-505	-303	-178	-93.18	55.00	-	-	-	-	1,954

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)															(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2
Cashflow From Operations	100.0%	213*	-2,344	-3,318	-71.62	6,114	-2,521	-2,347	1,777	-427	817	2,842	767	-32.14	-637	-
Share Based Compensation	-21.6%	331	422	538	1,146	1,053	927	1,015	854	852	593	158	226	134	93.00	-
Cashflow From Investing	60.8%	-254	-648	78.00	-5,883	5,879	-2,647	-831	-1,860	-6,044	-2,166	-1,375	-146	-28.88	271	-
Cashflow From Financing	255.4%	1,681	-1,082	6,551	2,628	-10,782	1,318	5,826	-2,008	33.00	-150	10,950	300	750	-12.00	-
Buy Backs	-	-	-	-	-	-	-	-1,975	1,976	-	-	-	-	-	-	-

UPXI Income Statement

2023-12-31

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
Revenue	$ 21,827,827	$ 26,741,562	$ 49,175,469	$ 37,960,361
Cost of Revenue	13,556,574	16,655,117	32,196,367	22,056,433
Gross profit	8,271,253	10,086,445	16,979,102	15,903,928
Operating expenses
Sales and marketing	2,691,368	3,297,144	5,540,035	5,024,613
Distribution costs	3,247,554	3,575,545	6,098,170	6,063,379
General and administrative expenses	2,303,220	2,517,651	4,559,148	4,645,497
Share-based compensation	330,584	1,052,847	752,471	1,980,173
Amortization of acquired intangible assets	1,157,029	1,102,756	2,343,850	1,832,665
Depreciation	328,619	240,958	614,703	435,455
Total Operating expenses	10,058,374	11,786,901	19,908,377	19,981,782
Loss from operations	(1,787,121)	(1,700,456)	(2,929,275)	(4,077,854)
Other income (expense), net
Change in derivative liability	0	(3,540)	0	(1,770)
Interest (expense) income, net	(1,077,084)	(1,789,299)	(1,951,269)	(2,222,777)
Other income (expense), net	(1,077,084)	(1,792,839)	(1,951,269)	(2,224,547)
Income (loss) on operations before income tax	(2,864,205)	(3,493,295)	(4,880,544)	(6,302,401)
Gain on sale of Infusionz and select assets	0	7,564,363	0	7,564,363
Gain (loss) from the sale of Interactive Offers	(39,691)	0	340,933
Lease settlement, California facility	61,138	0	61,138
Lease impairment, Delray Beach facility	(289,968)	0	(289,968)
(Loss) income from discontinued operations	0
Income tax benefit (expense)	694,807	(755,253)	1,167,174	(47,052)
Net income (loss) from continuing operations	(2,437,919)	3,315,815	(3,601,267)	1,214,910
(Loss) income from discontinued operations	0	(731,717)	(193,040)	(1,376,332)
Net loss attributable to non-controlling interest	0	85,581	0	233,586
Net income (loss) attributable to Upexi, Inc.	$ (2,437,919)	$ 2,669,679	$ (3,794,307)	$ 72,164
Basic income (loss) per share:
Income (loss) per share from continuing operations	$ (0.12)	$ 0.19	$ (0.19)	$ 0.08
(Loss) income per share from discontinued operations	0	(0.04)	(0.01)	(0.08)
Total income (loss) per share	(0.12)	0.15	(0.18)	0.00
Diluted income (loss) per share:
Income (loss) per share from continuing operations	(0.12)	0.17	(0.18)	0.07
(Loss) income per share from discontinued operations	0	(0.3)	0	(0.07)
Total income (loss) per share	$ (0.12)	$ 0.14	$ (0.18)	$ 0.07
Basic weighted average shares outstanding	20,306,871	17,540,427	20,275,745	15,452,453
Fully diluted weighted average shares outstanding	20,306,871	19,030,705	20,275,745	17,220,564

UPXI Balance Sheet

2023-12-31

CONDENSED CONSOLDIATED BALANCE SHEETS (UNAUDITED) - USD ($)	Dec. 31, 2023	Jun. 30, 2023
Current assets
Cash	$ 1,844,420	$ 4,492,291
Accounts receivable	5,377,244	7,163,564
Inventory	14,663,908	11,557,128
Due from Bloomios	0	845,443
Prepaid expenses and other receivables	697,559	1,307,299
Current assets of discontinued operations	0	89,989
Total current assets	22,583,131	25,455,714
Property and equipment, net	7,600,398	7,526,463
Intangible assets, net	11,298,110	13,571,960
Goodwill	11,808,571	10,251,281
Deferred tax asset	6,771,230	5,604,056
Other assets	441,844	96,728
Assets held for sale	0	936,054
Right-of-use asset	1,657,463	410,811
Total other assets	39,577,616	38,397,353
Total assets	62,160,747	63,853,067
Current liabilities
Accounts payable	3,017,764	3,969,746
Accrued compensation	495,228	533,842
Deferred revenue	104,149	0
Accrued liabilities	2,658,347	3,365,562
Acquisition payable	300,000	0
Current portion of notes payable	4,206,474	1,302,021
Current portion of convertible notes payable	0	1,254,167
Current portion of acquisition note payable	8,483,028	5,656,620
Current portion of related party note payable	0	1,429,356
Line of Credit	4,167,377	882,845
Current portion of operating lease payable	823,702	419,443
Current liabilities of discontinued operations	0	792,408
Total current liabilities	24,256,069	19,606,010
Operating lease payable, net of current portion	1,162,687	163,359
Related party note payable	1,459,630	0
Convertible notes payable	2,150,000	895,833
Acquisition notes payable, net of current	3,199,683	7,605,085
Notes payable, net of current portion	4,470,017	7,746,157
Total long-term liabilities	12,442,017	16,410,434
Stockholders' equity
Preferred stock, $0.001 par value, 100,000,000 shares authorized, and 500,000 and 500,000 shares issued and outstanding, respectively	500	500
Common stock, $0.001 par value, 100,000,000 shares authorized, and 20,397,779 and 16,713,345 shares issued and outstanding, respectively	20,307	20,216
Additional paid in capital	52,437,336	51,522,229
Accumulated deficit	(26,995,482)	(23,201,175)
Total stockholders' equity attributable to Upexi, Inc.	25,462,661	28,341,770
Non-controlling interest in subsidiary		(505,147)
Total stockholders' equity	25,462,661	27,836,623
Total liabilities and stockholders' equity	$ 62,160,747	$ 63,853,067

About Upexi Inc

Upexi, Inc. manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. Upexi, Inc. was incorporated in 2018 and is headquartered in Clearwater, Florida.

CEO	Mr. Allan J. Marshall
WEBSITE	upexi.com
INDUSTRY	Internet Retail
EMPLOYEES	130

Upexi Inc Frequently Asked Questions

What is the ticker symbol for Upexi Inc? What does UPXI stand for in stocks?

UPXI is the stock ticker symbol of Upexi Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Upexi Inc (UPXI)?

As of Fri Apr 26 2024, market cap of Upexi Inc is 10.44 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of UPXI stock?

You can check UPXI's fair value in chart for subscribers.

What is the fair value of UPXI stock?

You can check UPXI's fair value in chart for subscribers. The fair value of Upexi Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Upexi Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for UPXI so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Upexi Inc a good stock to buy?

The fair value guage provides a quick view whether UPXI is over valued or under valued. Whether Upexi Inc is cheap or expensive depends on the assumptions which impact Upexi Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for UPXI.

What is Upexi Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 26 2024, UPXI's PE ratio (Price to Earnings) is -0.46 and Price to Sales (PS) ratio is 0.11. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. UPXI PE ratio will change depending on the future growth rate expectations of investors.